Vermillion & White Wealth Management Group’s Novo Nordisk NVO Stock Holding History

Vermillion & White Wealth Management Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-241	Closed	-$12.3K	–	371
2025 Q4	$12.3K	Sell	241 -50	-17%	-$2.56K	0.01%	296
2025 Q3	$16.2K	Buy	291 +55	+23%	+$3.22K	0.01%	278
2025 Q2	$16.3K	Hold	236	–	–	0.01%	247
2025 Q1	$16.4K	Hold	236	–	–	0.01%	216
2024 Q4	$20.3K	Buy	+236	New	+$25.5K	0.02%	193
2024 Q3	–	Sell	-236	Closed	-$33.8K	–	371
2024 Q2	$33.8K	Hold	236	–	–	0.03%	156
2024 Q1	$30.4K	Hold	236	–	–	0.02%	152
2023 Q4	$24.5K	Buy	+236	New	+$23.3K	0.02%	134

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Vermillion & White Wealth Management Group's NVO Position: Q1 2026 in Review

Vermillion & White Wealth Management Group sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 241 shares — an estimated $12.3K sold.

Vermillion & White Wealth Management Group first reported a position in NVO in Q4 2023 and held it in 8 quarters. The position peaked at $33.8K in Q2 2024. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Vermillion & White Wealth Management Group reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
Vermillion & White Wealth Management Group sold 241 Novo Nordisk shares in Q1 2026, an estimated $12.3K.
Vermillion & White Wealth Management Group first reported a position in Novo Nordisk in Q4 2023 and held it in 8 quarters.
Vermillion & White Wealth Management Group's Novo Nordisk position peaked at $33.8K in Q2 2024.
1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Vermillion & White Wealth Management Group's 13F filing for Q1 2026, filed 14 May 2026.